The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
976
June 7, 1996
View Complete Issue         Table of Contents 2019 
Clarithromycin and Omeprazole for Helicobacter Pylori
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Clarithromycin and Omeprazole for Helicobacter Pylori
June 7, 1996 (Issue: 976)
The US Food and Drug Administration (FDA) recently approved the marketing of clarithromycin (Biaxin - Abbott), a macrolide antibiotic, and omeprazole (Prilosec - Astra Merck), a proton pump inhibitor, for concurrent use in treatment of duodenal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Clarithromycin and Omeprazole for Helicobacter Pylori
Article code: 976a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.